AGC株式会社
AGCグループはグローバルにバイオ医薬品原薬の受託開発・製造事業を展開しています。豊富な実績と高度な技術に基づき、バイオ医薬品原薬の開発段階から商用段階までをサポートしています。
会社カテゴリー：原薬・添加剤・中間体、製造受託機関(CMO)、医薬品製造、再生医療関連
主サービス提供地域：日本、アメリカ合衆国、ヨーロッパ(イギリス以外)、イギリス、アジア
製品・サービス詳細
Our teams of scientists have 25+ years of cell therapy development, manufacturing and regulatory experience, including bringing three commercial products to market.
AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including CD34+, T-Cells, NK Cells, and more.
Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. We also have flexible and cost-effective services for process development and pre-clinical needs.
Our teams of experts at two global sites bring the quality systems background and regulatory experience to help you navigate the important cell therapy product milestones, at any stage of the journey.
Cell Therapy Production and Manufacturing Services:
- Full life cycle stage support, from development up to clinical and commercial manufacturing
- Cell culture and modification in PD and cGMP environments
- Development of small, medium and large scale engineered cells, and analytical method development and qualification
- Manufacturing suites of different sizes and equipment with open and closed processes for autologous and allogeneic manufacturing
- Cells filled in vials and bags using a manual or semi-automated process, offering automated fill and finish at our U.S. site
- 160+ in-house analytical tests with custom designs for clinical and commercial supply
- Globally aligned quality systems and an innate understanding of cell and gene regulatory and inspection processes